|
May 10
|
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
|
|
May 6
|
Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
|
|
Apr 10
|
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
|
|
Apr 9
|
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
|
|
Apr 4
|
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
|
|
Mar 26
|
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
|
|
Mar 8
|
NeuroOne® to Participate in the 36th Annual Roth Conference
|
|
Dec 7
|
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
|
|
May 2
|
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
|
|
Apr 27
|
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|